REHABILITATION PROGRAMS FOR PEOPLE WITH NEUROMUSCULAR DISORDERS
Abstract
Neuromuscular diseases are inherited, chronic, degenerative and progressive. The main characteristics of neuromuscular diseases are: muscular weakness, contractures, scoliosis, respiratory insufficiency, cardiac affection, nutrition disturbances, dependence on the help of others, possible social isolation and physiological problems. Appropriate rehabilitation programs should influence all mentioned characteristics. A special unit for rehabilitation of patients with neuromuscular diseases within the Institute for rehabilitation of the Republic of Slovenia was established in 1993 at the initiative of the Muscular Dystrophy Association of Slovenia. The main aim of this establishment was to try to guide the patient and his family through the course of the disease. The article describes the work of the mentioned unit. Different clinical rehabilitation programs for people with neuromuscular diseases are presented and some research results of the unit are mentioned.Downloads
References
Zupan A. Ocenjevanje funkcijskega stanja bolnikov z živčno-mišičnimi boleznimi. Disertacija. Ljubljana: Univerza v Ljubljani, Medicinska fakulteta, 1992.
Petrof BJ: The molecular basis of activity-induced muscle injury in Duchenne muscular dystrophy. Am J Clin Nutr 1998; 67 (6): 1162–9.
Fowler WM Jr. Rehabilitation management of muscular dystrophy and related disorders: II. Comprehensive care. Arch Phys Med Rehabil 1982; 63: 322– 8.
Ziter FA, Allsop KG. Comprehensive treatment of childhood muscular dystrophy. Rocky Mt Med J 1975; 72: 329–33.
Zupan A. Device for stretching contractures in muscular dystrophy patients. In: Bühler C, Knops H, eds. Assistive technology on the threshold of the new millennium. Amsterdam /etc./: IOS Press, 1999: 560–3.
Adams MA, Chandler LS. Effects of physical therapy program on vital capacity of patients with muscular dystrophy. Phys Ther 1974; 54: 494–6.
Estrup C, Lyager S, Noreaa N, Olsen C. Effect of respiratory muscle training in patient with neuromuscular diseases and in normals. Respiration, 1986; 50: 36–43.
Zupan A, Gruenfeld M. Učinek dihalnih vaj pri težje prizadetih otrocih in mladostnikih z mišičnimi in živčno-mišičnimi boleznimi. Zdrav Vest 1990; 59: 93–5.
Di Marco AF, Keeling JS, DiMarco MS, Jacobs I, Shields R, Altose MD. The effects of inspiratory resistive training on respiratory muscle function in patients with muscular dystrophy. Muscle and Nerve, 1985; 8: 284–90.
Smith PEM, Coakley JH, Edwards RHT. Respiratory muscle training in Duchenne muscular dystrophy. Muscle Nerve 1988; 7: 784–5.
Aldrich JK, Karpel JP, Uhrlass RM, Sparapani MA, Eramo D, Ferranti R. Weaning from mechanical ventiation: adjunctive use of inspiratory muscle resistive training. Crit Care Med 1989; 17: 143–7.
Zupan A, Pražnikar A, Sardoč M: Inspiratory vs Expiratory Muscle Training in Children with Neuromuscular Diseases. Xth International Congress on Neuromuscular Diseases, 7-12 July 2002, Vancouver, Canada. J. Neurol. Sci. 2002;199, Suppl 1: S32.
Zupan A. Cardiovascular aberrations in patients with neuromuscular diseases. Acta Cardiomiologica 1995; 7 (2): 107–11.
Zupan A. Sedežna ortotika. In: Burger H ur. Ortopedska obutev in ortoze. 12. dnevi rehabilitacijske medicine: zbornik predavanj, 16. in 17. marec 2001. Ljubljana: Inštitut Republike Slovenije za rehabilitacijo, 2001: 107–13.
Zupan A. Kako nudimo fizično pomoč mišično obolelim. Ljubljana: Društvo mišično obolelih Slovenije, 1993.
Salmons S, Vrbova G. The influence of activity on some contractile characteristics of mammalian fast and slow muscle. J Physiol 1969; 201: 535–49.
Buchthal F, Kamieniecka Z, Schmalbruch H. Fibre types in normal and diseased human muscles and their physiological correlates. In: Milhorat AT ed. Exploratory Concepts in Muscular Dystrophy, II. Amsterdam: Excerpta Medica 1974: 526–51.
Zupan A. Long-term electrical stimulation of muscles in children with Duchenne and Becker muscular dystrophy. Muscle Nerve 1992; 15 (3): 362–7.
Pavlin R. Ubikinon (koencim Q10). Zdrav Vestn 1997; 66: 137–40.
Rauchova H, Drahota Z, Lenaz G. Function of coenzyme Q in the cell: some biochemical and physiological properties. Physiol Rev 1995; 44: 209–16.
Richter C, Gogvadze V, Laffranchi R et al. Oxidants in mitochondria: from physiology to diseases. Biochim Biophys Aacta 1995; 1271: 67–74.
Folkers K, Simonsen R. Two successful double-blind trials with coenzyme Q10 on muscular dystrophies and neurogenic atrophies. Biochim Biophys Acta 1995; 1271: 281–6.
Kumar E, Zupan A, Pražnikar A. Učinek koencima Q10 na funkcijske zmogljivosti bolnikov z živčno-mišičnimi boleznimi. Gib 2000; 21 (1): 17–22.
The Author transfers to the Publisher (Zdravniški vestnik/Slovenian Medical Journal) all economic copyrights following form Article 22 of the Slovene Copyright and Related Rights Act (ZASP), including the right of reproduction, the right of distribution, the rental right, the right of public performance, the right of public transmission, the right of public communication by means of phonograms and videograms, the right of public presentation, the right of broadcasting, the right of rebroadcasting, the right of secondary broadcasting, the right of communication to the public, the right of transformation, the right of audiovisual adaptation and all other rights of the author according to ZASP.
The aforementioned rights are transferred non-exclusively, for an unlimited number of editions, for the term of the statutory
The Author can make use of his work himself or transfer subjective rights to others only after 3 months from date of first publishing in the journal Zdravniški vestnik/Slovenian Medical Journal.
The Publisher (Zdravniški vestnik/Slovenian Medical Journal) has the right to transfer the rights, acquired parties without explicit consent of the Author.
The Author consents that the Article be published under the Creative Commons BY-NC 4.0 (attribution-non-commercial) or comparable licence.
